Canadian biotech company Cytophage Technologies Inc. has been awarded $250,000 USD in non-dilutive funding to develop biological solutions for plant bacterial challenges at the Donald…
Manitoba biotech company Cytophage Technologies Inc. has been awarded $431,000 in government funding to help test a new way of fighting bacterial infections in swine without using antibiotics.
Award-winning Cytophage Technologies Inc. today announced it is about to begin animal testing on a throat and nasal spray that will stop infection by the SARS-CoV-2 virus and its variants…
Momentum is building this month at Winnipeg’s Cytophage Inc., as Dr. Steven Theriault, CEO, will be featured on the Interactive Investment forum — BioPub. It’s the fourth notable presentation of its kind this
AS THE WORLD FIGHTS THE SARS-COV-2 VIRUS causing the COVID-19 pandemic, another group of dangerous pathogens looms in the background. The threat of antibiotic-resistant bacteria has been growing for years and appears to be getting worse.
Award Winning Virologist Shares Update On Scientific Advancement. With the abundance of information on Covid-19 at our disposal, it can sometime be overwhelming and difficult to separate fact from fiction.
Bactériophages. Ces virus naturels pourraient pourtant être à l’origine d’un nouveau traitement révolutionnaire contre les infections bactériennes résistantes aux antibiotiques, mis au point par un scientifique winnipégois.
One to watch: Steven Theriault’s research on bacteriophages has put him at the cutting edge of a potential bio-medical revolution
Antimicrobial resistance in animals and humans could render antibiotics useless in the future. Cytophage pitched its solution for natural bacteriophage products at FoodBytes! this week.
Originally focused on the human health sector, Cytophage Technologies has pivoted to animal health. As the company prepares clinical trials for its bacteriophage technology…
Before the discovery of penicillin almost a hundred years ago, doctors relied on other treatments to fight deadly infections. Now, after almost a century of overusing antibiotics, many infections…
Bacteriophage therapy has unlimited uses and is effective in eradicating bacterial disease and infection in three key areas.
In food safety, our phages help prevent disease and the spread of disease, without introducing antibiotics into the food chain or the environment.
Cytophage is developing bacteriophages that will reduce and ultimately replace the use of antibiotics for illness prevention and growth enhancement in livestock, starting with poultry.
In human health, phages can address a full range of bacterial illnesses and conditions, from treating acne and eczema, alleviating internal bacterial infections such as pneumonia, preventing wound infections and battling outbreaks such as cholera or diphtheria.
Phages can also be used for the decontamination of hospital surfaces and counters, tools and instruments, beds and curtains, and anywhere else bacterial contamination is a concern.
Bacteriophages are organisms that infect and kill bacterial cells. These natural killers of bacteria can overcome all of the cellular or organism-level defences.
Bacteriophages are organisms that infect and kill bacterial cells. These natural killers of bacteria can overcome all of the cellular or organism-level defences.
We can win the war against battlefield infection.
Cytophage was selected for the Defense Innovation Award 2019.
Winner of 2018 Nutreco Feed Tech Challenge
For our breakthrough innovation to help feed the world.
Cytophage Technologies Inc. © 2019